Merck Tbk. vs Midi Utama Indonesia Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Midi Utama Indonesia Tbk. trades at Rp282 (market cap 9.5T, 1.62M 24h volume). The key difference: Midi Utama Indonesia Tbk. is far larger — about 5.6× Merck Tbk.'s market cap, and Midi Utama Indonesia Tbk. is more actively traded (1.62M versus 37.6K). Which is the better fit depends on your goals.
| MERK | MIDI | |
|---|---|---|
Market Cap | 1.7T | 9.5T |
Volume | 37.6K | 1.62M |
Lot | 376 | 16.19K |
Turnover | 144.47M | 454.66M |
Average Price | 3,842.23 | 280.76 |
Value | 144.47M | 454.66M |
Indicative Equilibrium Price | 3,840 | 282 |
Indicative Equilibrium Volume | 7 | 803 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Read more on MIDI →